- Home
- ALGS
as 02-21-2025 4:00pm EST
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 118.8M | IPO Year: | 2020 |
| Target Price: | $75.00 | AVG Volume (30 days): | 263.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -12.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.76 - $46.80 | Next Earning Date: | 03-11-2025 |
| Revenue: | $5,997,000 | Revenue Growth: | -63.40% |
| Revenue Growth (this year): | -75.4% | Revenue Growth (next year): | -64.40% |
Latest Aligos Therapeutics Inc. News
ALGS Breaking Stock News: Dive into ALGS Ticker-Specific Updates for Smart Investing
GlobeNewswire
10 days ago
Aligos Therapeutics Announces $105 Million Private Placement Financing
Simply Wall St.
14 days ago
Here's Why Aligos Therapeutics (NASDAQ:ALGS) Must Use Its Cash Wisely
Zacks
18 days ago
PTC Therapeutics (PTCT) Moves 9.0% Higher: Will This Strength Last?
Insider Monkey
a month ago
Here’s Why Aligos Therapeutics, Inc. (ALGS) Is Skyrocketing
Simply Wall St.
2 months ago
Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) biggest owners are retail investors who got richer after stock soared 17% last week
GlobeNewswire
2 months ago
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
3 months ago
Aligos Therapeutics to Present at Investor Conferences in December
GlobeNewswire
3 months ago
Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024
Compare ALGS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALGS Aligos Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.